Global Platinum-based Anticancer Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Platinum-based Anticancer Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Platinum-based Anticancer Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Platinum-based Anticancer Drugs by Country/Region, 2017, 2022 & 2028

2.2 Platinum-based Anticancer Drugs Segment by Type

2.2.1 Cisplatin

2.2.2 Carboplatin

2.2.3 Oxaliplatin

2.2.4 Nedaplatin

2.2.5 Others

2.3 Platinum-based Anticancer Drugs Sales by Type

2.3.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Platinum-based Anticancer Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Platinum-based Anticancer Drugs Sale Price by Type (2017-2022)

2.4 Platinum-based Anticancer Drugs Segment by Application

2.4.1 Testicular Cancer

2.4.2 Osteosarcoma

2.4.3 Breast Cancer

2.4.4 Esophageal Cancer

2.4.5 NSCLC

2.4.6 Other

2.5 Platinum-based Anticancer Drugs Sales by Application

2.5.1 Global Platinum-based Anticancer Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Platinum-based Anticancer Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Platinum-based Anticancer Drugs Sale Price by Application (2017-2022)

3 Global Platinum-based Anticancer Drugs by Company

3.1 Global Platinum-based Anticancer Drugs Breakdown Data by Company

3.1.1 Global Platinum-based Anticancer Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Company (2020-2022)

3.2 Global Platinum-based Anticancer Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Platinum-based Anticancer Drugs Revenue by Company (2020-2022)

3.2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Platinum-based Anticancer Drugs Sale Price by Company

3.4 Key Manufacturers Platinum-based Anticancer Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Platinum-based Anticancer Drugs Product Location Distribution

3.4.2 Players Platinum-based Anticancer Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Platinum-based Anticancer Drugs by Geographic Region

4.1 World Historic Platinum-based Anticancer Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Platinum-based Anticancer Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Platinum-based Anticancer Drugs Annual Revenue by Geographic Region

4.2 World Historic Platinum-based Anticancer Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Platinum-based Anticancer Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Platinum-based Anticancer Drugs Annual Revenue by Country/Region

4.3 Americas Platinum-based Anticancer Drugs Sales Growth

4.4 APAC Platinum-based Anticancer Drugs Sales Growth

4.5 Europe Platinum-based Anticancer Drugs Sales Growth

4.6 Middle East & Africa Platinum-based Anticancer Drugs Sales Growth

5 Americas

5.1 Americas Platinum-based Anticancer Drugs Sales by Country

5.1.1 Americas Platinum-based Anticancer Drugs Sales by Country (2017-2022)

5.1.2 Americas Platinum-based Anticancer Drugs Revenue by Country (2017-2022)

5.2 Americas Platinum-based Anticancer Drugs Sales by Type

5.3 Americas Platinum-based Anticancer Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Platinum-based Anticancer Drugs Sales by Region

6.1.1 APAC Platinum-based Anticancer Drugs Sales by Region (2017-2022)

6.1.2 APAC Platinum-based Anticancer Drugs Revenue by Region (2017-2022)

6.2 APAC Platinum-based Anticancer Drugs Sales by Type

6.3 APAC Platinum-based Anticancer Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Platinum-based Anticancer Drugs by Country

7.1.1 Europe Platinum-based Anticancer Drugs Sales by Country (2017-2022)

7.1.2 Europe Platinum-based Anticancer Drugs Revenue by Country (2017-2022)

7.2 Europe Platinum-based Anticancer Drugs Sales by Type

7.3 Europe Platinum-based Anticancer Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Platinum-based Anticancer Drugs by Country

8.1.1 Middle East & Africa Platinum-based Anticancer Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Platinum-based Anticancer Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Platinum-based Anticancer Drugs Sales by Type

8.3 Middle East & Africa Platinum-based Anticancer Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Platinum-based Anticancer Drugs

10.3 Manufacturing Process Analysis of Platinum-based Anticancer Drugs

10.4 Industry Chain Structure of Platinum-based Anticancer Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Platinum-based Anticancer Drugs Distributors

11.3 Platinum-based Anticancer Drugs Customer

12 World Forecast Review for Platinum-based Anticancer Drugs by Geographic Region

12.1 Global Platinum-based Anticancer Drugs Market Size Forecast by Region

12.1.1 Global Platinum-based Anticancer Drugs Forecast by Region (2023-2028)

12.1.2 Global Platinum-based Anticancer Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Platinum-based Anticancer Drugs Forecast by Type

12.7 Global Platinum-based Anticancer Drugs Forecast by Application

13 Key Players Analysis

13.1 Sanofi-Aventis

13.1.1 Sanofi-Aventis Company Information

13.1.2 Sanofi-Aventis Platinum-based Anticancer Drugs Product Offered

13.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi-Aventis Main Business Overview

13.1.5 Sanofi-Aventis Latest Developments

13.2 Yakult honsha

13.2.1 Yakult honsha Company Information

13.2.2 Yakult honsha Platinum-based Anticancer Drugs Product Offered

13.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Yakult honsha Main Business Overview

13.2.5 Yakult honsha Latest Developments

13.3 Dr Reddy's laboratories

13.3.1 Dr Reddy's laboratories Company Information

13.3.2 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offered

13.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Dr Reddy's laboratories Main Business Overview

13.3.5 Dr Reddy's laboratories Latest Developments

13.4 Sun Pharmaceutical

13.4.1 Sun Pharmaceutical Company Information

13.4.2 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

13.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sun Pharmaceutical Main Business Overview

13.4.5 Sun Pharmaceutical Latest Developments

13.5 Teva

13.5.1 Teva Company Information

13.5.2 Teva Platinum-based Anticancer Drugs Product Offered

13.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Teva Main Business Overview

13.5.5 Teva Latest Developments

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Company Information

13.6.2 Fresenius Kabi Platinum-based Anticancer Drugs Product Offered

13.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Kabi Main Business Overview

13.6.5 Fresenius Kabi Latest Developments

13.7 Hospira(Pfizer)

13.7.1 Hospira(Pfizer) Company Information

13.7.2 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offered

13.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hospira(Pfizer) Main Business Overview

13.7.5 Hospira(Pfizer) Latest Developments

13.8 Mylan

13.8.1 Mylan Company Information

13.8.2 Mylan Platinum-based Anticancer Drugs Product Offered

13.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Main Business Overview

13.8.5 Mylan Latest Developments

13.9 Taj Pharmaceuticals

13.9.1 Taj Pharmaceuticals Company Information

13.9.2 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offered

13.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Taj Pharmaceuticals Main Business Overview

13.9.5 Taj Pharmaceuticals Latest Developments

13.10 Jiangsu Hengrui Medicine

13.10.1 Jiangsu Hengrui Medicine Company Information

13.10.2 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offered

13.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Jiangsu Hengrui Medicine Main Business Overview

13.10.5 Jiangsu Hengrui Medicine Latest Developments

13.11 Nanjing Pharmaceutical Factory

13.11.1 Nanjing Pharmaceutical Factory Company Information

13.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offered

13.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Nanjing Pharmaceutical Factory Main Business Overview

13.11.5 Nanjing Pharmaceutical Factory Latest Developments

13.12 Jiangsu Aosaikang Pharmaceutical

13.12.1 Jiangsu Aosaikang Pharmaceutical Company Information

13.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offered

13.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview

13.12.5 Jiangsu Aosaikang Pharmaceutical Latest Developments

13.13 Qilu Pharmaceutical

13.13.1 Qilu Pharmaceutical Company Information

13.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offered

13.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Qilu Pharmaceutical Main Business Overview

13.13.5 Qilu Pharmaceutical Latest Developments

13.14 Hisun Pharmaceutical

13.14.1 Hisun Pharmaceutical Company Information

13.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

13.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Hisun Pharmaceutical Main Business Overview

13.14.5 Hisun Pharmaceutical Latest Developments

13.15 Luoxin

13.15.1 Luoxin Company Information

13.15.2 Luoxin Platinum-based Anticancer Drugs Product Offered

13.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Luoxin Main Business Overview

13.15.5 Luoxin Latest Developments

13.16 Lingnan Pharmacy

13.16.1 Lingnan Pharmacy Company Information

13.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offered

13.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Lingnan Pharmacy Main Business Overview

13.16.5 Lingnan Pharmacy Latest Developments

13.17 Hansoh Pharma

13.17.1 Hansoh Pharma Company Information

13.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Product Offered

13.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Hansoh Pharma Main Business Overview

13.17.5 Hansoh Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. Platinum-based Anticancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Platinum-based Anticancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cisplatin

Table 4. Major Players of Carboplatin

Table 5. Major Players of Oxaliplatin

Table 6. Major Players of Nedaplatin

Table 7. Major Players of Others

Table 8. Global Platinum-based Anticancer Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Platinum-based Anticancer Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Platinum-based Anticancer Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Platinum-based Anticancer Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Platinum-based Anticancer Drugs Revenue by Application (2017-2022)

Table 16. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Platinum-based Anticancer Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Platinum-based Anticancer Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Platinum-based Anticancer Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Platinum-based Anticancer Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Platinum-based Anticancer Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Platinum-based Anticancer Drugs Producing Area Distribution and Sales Area

Table 24. Players Platinum-based Anticancer Drugs Products Offered

Table 25. Platinum-based Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Platinum-based Anticancer Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Platinum-based Anticancer Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Platinum-based Anticancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Platinum-based Anticancer Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Platinum-based Anticancer Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Platinum-based Anticancer Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Platinum-based Anticancer Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Platinum-based Anticancer Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Platinum-based Anticancer Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Platinum-based Anticancer Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Platinum-based Anticancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Platinum-based Anticancer Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Platinum-based Anticancer Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Platinum-based Anticancer Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Platinum-based Anticancer Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Platinum-based Anticancer Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Platinum-based Anticancer Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Platinum-based Anticancer Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Platinum-based Anticancer Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Platinum-based Anticancer Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Platinum-based Anticancer Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Platinum-based Anticancer Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Platinum-based Anticancer Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Platinum-based Anticancer Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Platinum-based Anticancer Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Platinum-based Anticancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Platinum-based Anticancer Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Platinum-based Anticancer Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Platinum-based Anticancer Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Platinum-based Anticancer Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Platinum-based Anticancer Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Platinum-based Anticancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Platinum-based Anticancer Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Platinum-based Anticancer Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Platinum-based Anticancer Drugs

Table 69. Key Market Challenges & Risks of Platinum-based Anticancer Drugs

Table 70. Key Industry Trends of Platinum-based Anticancer Drugs

Table 71. Platinum-based Anticancer Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Platinum-based Anticancer Drugs Distributors List

Table 74. Platinum-based Anticancer Drugs Customer List

Table 75. Global Platinum-based Anticancer Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Platinum-based Anticancer Drugs Sales Market Forecast by Region

Table 77. Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Platinum-based Anticancer Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Platinum-based Anticancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Platinum-based Anticancer Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Platinum-based Anticancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Platinum-based Anticancer Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Platinum-based Anticancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Platinum-based Anticancer Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Platinum-based Anticancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Platinum-based Anticancer Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Platinum-based Anticancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Platinum-based Anticancer Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Platinum-based Anticancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Sanofi-Aventis Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Sanofi-Aventis Platinum-based Anticancer Drugs Product Offered

Table 97. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Sanofi-Aventis Main Business

Table 99. Sanofi-Aventis Latest Developments

Table 100. Yakult honsha Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Yakult honsha Platinum-based Anticancer Drugs Product Offered

Table 102. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Yakult honsha Main Business

Table 104. Yakult honsha Latest Developments

Table 105. Dr Reddy's laboratories Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offered

Table 107. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Dr Reddy's laboratories Main Business

Table 109. Dr Reddy's laboratories Latest Developments

Table 110. Sun Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 112. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Sun Pharmaceutical Main Business

Table 114. Sun Pharmaceutical Latest Developments

Table 115. Teva Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Teva Platinum-based Anticancer Drugs Product Offered

Table 117. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Teva Main Business

Table 119. Teva Latest Developments

Table 120. Fresenius Kabi Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Fresenius Kabi Platinum-based Anticancer Drugs Product Offered

Table 122. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Fresenius Kabi Main Business

Table 124. Fresenius Kabi Latest Developments

Table 125. Hospira(Pfizer) Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offered

Table 127. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Hospira(Pfizer) Main Business

Table 129. Hospira(Pfizer) Latest Developments

Table 130. Mylan Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Mylan Platinum-based Anticancer Drugs Product Offered

Table 132. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Mylan Main Business

Table 134. Mylan Latest Developments

Table 135. Taj Pharmaceuticals Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offered

Table 137. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Taj Pharmaceuticals Main Business

Table 139. Taj Pharmaceuticals Latest Developments

Table 140. Jiangsu Hengrui Medicine Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offered

Table 142. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Jiangsu Hengrui Medicine Main Business

Table 144. Jiangsu Hengrui Medicine Latest Developments

Table 145. Nanjing Pharmaceutical Factory Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offered

Table 147. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Nanjing Pharmaceutical Factory Main Business

Table 149. Nanjing Pharmaceutical Factory Latest Developments

Table 150. Jiangsu Aosaikang Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 151. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 152. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Jiangsu Aosaikang Pharmaceutical Main Business

Table 154. Jiangsu Aosaikang Pharmaceutical Latest Developments

Table 155. Qilu Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 156. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 157. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Qilu Pharmaceutical Main Business

Table 159. Qilu Pharmaceutical Latest Developments

Table 160. Hisun Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 161. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 162. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Hisun Pharmaceutical Main Business

Table 164. Hisun Pharmaceutical Latest Developments

Table 165. Luoxin Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 166. Luoxin Platinum-based Anticancer Drugs Product Offered

Table 167. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 168. Luoxin Main Business

Table 169. Luoxin Latest Developments

Table 170. Lingnan Pharmacy Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 171. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offered

Table 172. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 173. Lingnan Pharmacy Main Business

Table 174. Lingnan Pharmacy Latest Developments

Table 175. Hansoh Pharma Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 176. Hansoh Pharma Platinum-based Anticancer Drugs Product Offered

Table 177. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 178. Hansoh Pharma Main Business

Table 179. Hansoh Pharma Latest Developments

List of Figures

Figure 1. Picture of Platinum-based Anticancer Drugs

Figure 2. Platinum-based Anticancer Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Platinum-based Anticancer Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Platinum-based Anticancer Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Platinum-based Anticancer Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cisplatin

Figure 10. Product Picture of Carboplatin

Figure 11. Product Picture of Oxaliplatin

Figure 12. Product Picture of Nedaplatin

Figure 13. Product Picture of Others

Figure 14. Global Platinum-based Anticancer Drugs Sales Market Share by Type in 2021

Figure 15. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Platinum-based Anticancer Drugs Consumed in Testicular Cancer

Figure 17. Global Platinum-based Anticancer Drugs Market: Testicular Cancer (2017-2022) & (K Units)

Figure 18. Platinum-based Anticancer Drugs Consumed in Osteosarcoma

Figure 19. Global Platinum-based Anticancer Drugs Market: Osteosarcoma (2017-2022) & (K Units)

Figure 20. Platinum-based Anticancer Drugs Consumed in Breast Cancer

Figure 21. Global Platinum-based Anticancer Drugs Market: Breast Cancer (2017-2022) & (K Units)

Figure 22. Platinum-based Anticancer Drugs Consumed in Esophageal Cancer

Figure 23. Global Platinum-based Anticancer Drugs Market: Esophageal Cancer (2017-2022) & (K Units)

Figure 24. Platinum-based Anticancer Drugs Consumed in NSCLC

Figure 25. Global Platinum-based Anticancer Drugs Market: NSCLC (2017-2022) & (K Units)

Figure 26. Platinum-based Anticancer Drugs Consumed in Other

Figure 27. Global Platinum-based Anticancer Drugs Market: Other (2017-2022) & (K Units)

Figure 28. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2017-2022)

Figure 29. Global Platinum-based Anticancer Drugs Revenue Market Share by Application in 2021

Figure 30. Platinum-based Anticancer Drugs Revenue Market by Company in 2021 ($ Million)

Figure 31. Global Platinum-based Anticancer Drugs Revenue Market Share by Company in 2021

Figure 32. Global Platinum-based Anticancer Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 33. Global Platinum-based Anticancer Drugs Revenue Market Share by Geographic Region in 2021

Figure 34. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2017-2022)

Figure 35. Global Platinum-based Anticancer Drugs Revenue Market Share by Country/Region in 2021

Figure 36. Americas Platinum-based Anticancer Drugs Sales 2017-2022 (K Units)

Figure 37. Americas Platinum-based Anticancer Drugs Revenue 2017-2022 ($ Millions)

Figure 38. APAC Platinum-based Anticancer Drugs Sales 2017-2022 (K Units)

Figure 39. APAC Platinum-based Anticancer Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Europe Platinum-based Anticancer Drugs Sales 2017-2022 (K Units)

Figure 41. Europe Platinum-based Anticancer Drugs Revenue 2017-2022 ($ Millions)

Figure 42. Middle East & Africa Platinum-based Anticancer Drugs Sales 2017-2022 (K Units)

Figure 43. Middle East & Africa Platinum-based Anticancer Drugs Revenue 2017-2022 ($ Millions)

Figure 44. Americas Platinum-based Anticancer Drugs Sales Market Share by Country in 2021

Figure 45. Americas Platinum-based Anticancer Drugs Revenue Market Share by Country in 2021

Figure 46. United States Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Canada Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Mexico Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Brazil Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. APAC Platinum-based Anticancer Drugs Sales Market Share by Region in 2021

Figure 51. APAC Platinum-based Anticancer Drugs Revenue Market Share by Regions in 2021

Figure 52. China Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Japan Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. South Korea Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Southeast Asia Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. India Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Australia Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Europe Platinum-based Anticancer Drugs Sales Market Share by Country in 2021

Figure 59. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country in 2021

Figure 60. Germany Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. France Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. UK Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Italy Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Russia Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Country in 2021

Figure 66. Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share by Country in 2021

Figure 67. Egypt Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. South Africa Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. Israel Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Turkey Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. GCC Country Platinum-based Anticancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 72. Manufacturing Cost Structure Analysis of Platinum-based Anticancer Drugs in 2021

Figure 73. Manufacturing Process Analysis of Platinum-based Anticancer Drugs

Figure 74. Industry Chain Structure of Platinum-based Anticancer Drugs

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles